Publication: A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica
Open/View Files
Date
2018
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group UK
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Estrada, K., C. W. Whelan, F. Zhao, P. Bronson, R. E. Handsaker, C. Sun, J. P. Carulli, et al. 2018. “A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.” Nature Communications 9 (1): 1929. doi:10.1038/s41467-018-04332-3. http://dx.doi.org/10.1038/s41467-018-04332-3.
Research Data
Abstract
Neuromyelitis optica (NMO) is a rare autoimmune disease that affects the optic nerve and spinal cord. Most NMO patients ( > 70%) are seropositive for circulating autoantibodies against aquaporin 4 (NMO-IgG+). Here, we meta-analyze whole-genome sequences from 86 NMO cases and 460 controls with genome-wide SNP array from 129 NMO cases and 784 controls to test for association with SNPs and copy number variation (total N = 215 NMO cases, 1244 controls). We identify two independent signals in the major histocompatibility complex (MHC) region associated with NMO-IgG+, one of which may be explained by structural variation in the complement component 4 genes. Mendelian Randomization analysis reveals a significant causal effect of known systemic lupus erythematosus (SLE), but not multiple sclerosis (MS), risk variants in NMO-IgG+. Our results suggest that genetic variants in the MHC region contribute to the etiology of NMO-IgG+ and that NMO-IgG+ is genetically more similar to SLE than MS.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service